InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Payne Fletcher. Director active across 1 company, notably Aptose Biosciences Inc.. In total, 2 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €7k. Activity tracked since 19 September 2022. The latest transaction was disclosed on 19 January 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations